5F-ADBICA

5F-ADBICA_structure.png

5F-ADBICA is a synthetic cannabinoid that has been used as a designer drug. It is a potent agonist of the cannabinoid receptors and is structurally related to other synthetic cannabinoids such as ADBICA and 5F-ADB.

Chemical Structure

5F-ADBICA belongs to the indole-3-carboxamide family. Its chemical structure includes a fluoropentyl chain, which is a common feature in many synthetic cannabinoids. The full chemical name of 5F-ADBICA is N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide.

Pharmacology

5F-ADBICA acts as a potent agonist at the CB1 and CB2 cannabinoid receptors. These receptors are part of the endocannabinoid system, which plays a role in regulating various physiological processes including pain sensation, mood, and appetite.

Legal Status

The legal status of 5F-ADBICA varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of medical use. For example, in the United States, it is listed as a Schedule I substance under the Controlled Substances Act.

Health Risks

The use of 5F-ADBICA has been associated with a range of adverse health effects. These can include tachycardia, hypertension, nausea, vomiting, and psychosis. Due to its potency and the variability in the composition of products containing synthetic cannabinoids, the risk of overdose and severe adverse effects is significant.

Detection in Biological Fluids

5F-ADBICA and its metabolites can be detected in biological fluids using various analytical techniques such as gas chromatography-mass spectrometry (GC-MS) and liquid chromatography-tandem mass spectrometry (LC-MS/MS). These methods are used in forensic and clinical toxicology to confirm exposure to the substance.

See Also

• Synthetic cannabinoids
• Cannabinoid receptor
• Endocannabinoid system
• Controlled Substances Act